Development of a RIPK1 degrader to enhance antitumor immunity.
Yu X, Lu D, Qi X, Paudel RR, Lin H, Holloman BL, Jin F, Xu L, Ding L, Peng W, Wang MC, Chen X, Wang J.
Yu X, et al. Among authors: ding l.
Nat Commun. 2024 Dec 16;15(1):10683. doi: 10.1038/s41467-024-55006-2.
Nat Commun. 2024.
PMID: 39681571
Free PMC article.